DIVISLAB's weekly performance was positive, with a return of 1.22%, outperforming its peers DRREDDY, SUNPHARMA, and CIPLA. The stock's volatility was relatively high at 38.77%, indicating a riskier investment. Despite this, the Sharpe Ratio of 0.13 suggests that the return was somewhat justified by the level of risk taken. Overall, DIVISLAB was a relatively strong performer this week, but investors should be cautious of its high volatility.

[Volatility: 38.77%]